The FDA granted full approval to selpercatinib for the treatment of patients with advanced lung cancer. The U.S. Food and Drug Administration (FDA) has approved selpercatinib (Retevmo) for the treatment of patients with locally...
Researchers highlight need for outreach and educational programs to address survivorship disparities.
Researchers describe their efforts to understand and improve cancer screening and treatment among underserved populations.
AACR conference explores the science of cancer disparities and what needs to be done to improve cancer outcomes for all people.
Air pollution research provides clues to how cancer starts, and KRAS-targeting drug appears to keep cancer at bay longer than standard of care, but questions remain.
Get your hearing checked periodically if you will be undergoing chemotherapy with neurotoxic effects.
Early-onset cancer is increasing globally, testing population-wide preventive DNA testing, and more from the week in cancer news.
The immune checkpoint inhibitor durvalumab was approved in combination with chemotherapy for certain biliary tract cancers that have spread. The U.S. Food and Drug Administration (FDA) has approved durvalumab (Imfinzi) in combination with the...
Fertility preservation does not impact outcomes for breast cancer patients, and ultraprocessed foods linked to increased risk of colorectal cancer in men.
Advanced cervical cancer rates are rising despite prevention and screening tools and more from the week in cancer news, selected by the editors of Cancer Today.
AACR Fellow Lewis C. Cantley, PhD, leads a national effort targeting triple-negative breast cancer and ovarian cancer with a novel drug combination.
Learn More